Relative Affinity of Calcium Pump Isoforms for Phospholamban Quantified by Fluorescence Resonance Energy Transfer

Journal of Molecular Biology

Volumn 402, Issue 1, 2010, Pages 210-216

  Hou, Zhanjia ^a   Robia, Seth L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Affinity; Calcium ATPase; Phospholamban; SERCA1a; SERCA2a

Indexed keywords

PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; ISOPROTEIN; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOG; EMBRYO; ENZYME STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE OVEREXPRESSION; HEART MUSCLE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN QUATERNARY STRUCTURE; QUANTITATIVE ANALYSIS; RABBIT; ANIMAL; CHEMISTRY; ENZYMOLOGY; METABOLISM; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM-BINDING PROTEINS; DOGS; FLUORESCENCE RESONANCE ENERGY TRANSFER; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; RABBITS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 77956117273     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.07.023     Document Type: Article

References (24)

1. Gwathmey J.K., Copelas L., MacKinnon R., Schoen F.J., Feldman M.D., Grossman W., Morgan J.P. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ. Res. 1987, 61:70-76.
2. Sipido, K. R. & Vangheluwe, P. Targeting sarcoplasmic reticulum Ca2+ uptake to improve heart failure: hit or miss. Circ. Res. 106, 230-233.
3. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 2003, 4:566-577.
4. Jorgensen A.O., Jones L.R. Localization of phospholamban in slow but not fast canine skeletal muscle fibers. An immunocytochemical and biochemical study. J. Biol. Chem. 1986, 261:3775-3781.
5. Ferrington D.A., Yao Q., Squier T.C., Bigelow D.J. Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. Biochemistry 2002, 41:13289-13296.
6. Reddy L.G., Autry J.M., Jones L.R., Thomas D.D. Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure. J. Biol. Chem. 1999, 274:7649-7655.
7. Lalli M.J., Yong J., Prasad V., Hashimoto K., Plank D., Babu G.J., et al. Sarcoplasmic reticulum Ca(2+) ATPase (SERCA) 1a structurally substitutes for SERCA2a in the cardiac sarcoplasmic reticulum and increases cardiac Ca(2+) handling capacity. Circ. Res. 2001, 89:160-167.
8. O'Donnell J.M., Pound K., Xu X., Lewandowski E.D. SERCA1 expression enhances the metabolic efficiency of improved contractility in post-ischemic heart. J. Mol. Cell. Cardiol. 2009, 47:614-621.
9. Kelly E.M., Hou Z., Bossuyt J., Bers D.M., Robia S.L. Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells. J. Biol. Chem. 2008, 283:12202-12211.
10. Hou Z., Kelly E.M., Robia S.L. Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex. J. Biol. Chem. 2008, 283:28996-29003.
11. Robia S.L., Campbell K.S., Kelly E.M., Hou Z., Winters D.L., Thomas D.D. Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex. Circ. Res. 2007, 101:1123-1129.
12. Bossuyt J., Despa S., Han F., Hou Z., Robia S.L., Lingrel J.B., Bers D.M. Isoform-specificity of the Na/K-ATPase association and regulation by phospholemman. J. Biol. Chem. 2009, 284:26749-26757.
13. 2+ ATPase. Proc. Natl Acad. Sci. USA 2003, 100:467-472.
14. 2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses. J. Biol. Chem. 2003, 278:47877-47889.
15. 2+ pump revealed with use of heterobifunctional cross-linking agents. J. Biol. Chem. 2003, 278:48348-48356.
16. Zhang K.M., Hu P., Wang S.W., Wright L.D., Wechsler A.S., Spratt J.A., Briggs F.N. Fast- and slow-twitch isoforms (SERCA1 and SERCA2a) of sarcoplasmic reticulum Ca-ATPase are expressed simultaneously in chronically stimulated muscle fibers. Pfluegers Arch. 1997, 433:766-772.
17. Salanova M., Schiffl G., Blottner D. Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest. Histochem. Cell Biol. 2009, 132:383-394.
18. Zhang K.M., Hu P., Wang S.W., Wright L.D., Wechsler A.S., Spratt J.A., Briggs F.N. The beta2-agonist salbutamol affects the expression of phospholamban and both isoforms of SERCA in canine skeletal muscle and blocks changes in these induced by neuromuscular stimulation. Pfluegers Arch. 1998, 435:511-517.
19. Brittsan A.G., Carr A.N., Schmidt A.G., Kranias E.G. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J. Biol. Chem. 2000, 275:12129-12135.
20. Reddy L.G., Jones L.R., Thomas D.D. Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study. Biochemistry 1999, 38:3954-3962.
21. Zal T., Gascoigne N.R. Photobleaching-corrected FRET efficiency imaging of live cells. Biophys. J. 2004, 86:3923-3939.
22. Förster T. Intermolecular energy migration and fluorescence. Ann. Phys. (Leipzig) 1948, 2:55-75.
23. Rizzo M.A., Springer G., Segawa K., Zipfel W.R., Piston D.W. Optimization of pairings and detection conditions for measurement of FRET between cyan and yellow fluorescent proteins. Microsc. Microanal. 2006, 12:238-254.
24. Vangheluwe P., Schuermans M., Zador E., Waelkens E., Raeymaekers L., Wuytack F. Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem. J. 2005, 389:151-159.